Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 15:59:03 UTC |
---|
Update Date | 2021-09-26 23:11:15 UTC |
---|
HMDB ID | HMDB0255956 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Olmesartan medoxomil |
---|
Description | (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate, also known as benicar or olmetec, belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate is a drug. Based on a literature review very few articles have been published on (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate. This compound has been identified in human blood as reported by (PMID: 31557052 ). Olmesartan medoxomil is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Olmesartan medoxomil is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=O)OCC1=C(C)OC(=O)O1)C(C)(C)O InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34) |
---|
Synonyms | Value | Source |
---|
Benicar | Kegg | Olmetec | Kegg | (5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid | Generator | Olmesartan medoxomil tablets | KEGG | (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid | Generator | 866, CS | MeSH | Benicar HCT | MeSH | Votum | MeSH | Medoxomil, olmesartan | MeSH | 5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346 | MeSH | HCT, Benicar | MeSH | Olmesartan medoxomil | MeSH |
|
---|
Chemical Formula | C29H30N6O6 |
---|
Average Molecular Weight | 558.595 |
---|
Monoisotopic Molecular Weight | 558.22268271 |
---|
IUPAC Name | (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate |
---|
Traditional Name | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}imidazole-4-carboxylate |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=O)OCC1=C(C)OC(=O)O1)C(C)(C)O |
---|
InChI Identifier | InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34) |
---|
InChI Key | UQGKUQLKSCSZGY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Biphenyls and derivatives |
---|
Direct Parent | Biphenyls and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Biphenyl
- Phenyltetrazole
- 1,2,4,5-tetrasubstituted imidazole
- Imidazole-4-carbonyl group
- Carbonic acid diester
- N-substituted imidazole
- Azole
- Heteroaromatic compound
- Imidazole
- Tetrazole
- Tertiary alcohol
- Carboxylic acid ester
- Carboxylic acid derivative
- Oxacycle
- Azacycle
- Monocarboxylic acid or derivatives
- Organoheterocyclic compound
- Alcohol
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic alcohol
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Olmesartan medoxomil,2TMS,isomer #1 | CCCC1=NC(C(C)(C)O[Si](C)(C)C)=C(C(=O)OCC2=C(C)OC(=O)O2)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C)C=C1 | 4531.5 | Semi standard non polar | 33892256 | Olmesartan medoxomil,2TMS,isomer #1 | CCCC1=NC(C(C)(C)O[Si](C)(C)C)=C(C(=O)OCC2=C(C)OC(=O)O2)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C)C=C1 | 4175.7 | Standard non polar | 33892256 | Olmesartan medoxomil,2TMS,isomer #1 | CCCC1=NC(C(C)(C)O[Si](C)(C)C)=C(C(=O)OCC2=C(C)OC(=O)O2)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C)C=C1 | 5705.5 | Standard polar | 33892256 | Olmesartan medoxomil,2TBDMS,isomer #1 | CCCC1=NC(C(C)(C)O[Si](C)(C)C(C)(C)C)=C(C(=O)OCC2=C(C)OC(=O)O2)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C(C)(C)C)C=C1 | 4815.0 | Semi standard non polar | 33892256 | Olmesartan medoxomil,2TBDMS,isomer #1 | CCCC1=NC(C(C)(C)O[Si](C)(C)C(C)(C)C)=C(C(=O)OCC2=C(C)OC(=O)O2)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C(C)(C)C)C=C1 | 4545.3 | Standard non polar | 33892256 | Olmesartan medoxomil,2TBDMS,isomer #1 | CCCC1=NC(C(C)(C)O[Si](C)(C)C(C)(C)C)=C(C(=O)OCC2=C(C)OC(=O)O2)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C(C)(C)C)C=C1 | 5629.8 | Standard polar | 33892256 |
| Show more...
---|